Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer | RSS News Feed

Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer - Latest News

RSS Feed for this news: Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer

Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research. The PERSEPHONE trial, a £2.6 million study which ... read more

Good News on Early Breast Cancer: Herceptin Treatment Can Be Shortened

The new study is the first to show that women with early-stage disease can safely cut back on Herceptin ... treated for six months, and 89.8 percent in the 12-month group. Disease-free survival means they had no signs of breast cancer, and the lack ... read more

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of targeted treatment could be as effective ... HER2-positive breast cancer.” The UK trial involved over 4,000 women with HER2-positive breast cancer that hadn’t spread to other parts of the body. They were given either 6 or 12 months of ... read more

Looking for another news?


Six Months of Trastuzumab Equal to 12 in Breast Ca

The study "marks the first steps towards reduction of treatment duration for many women with HER2-positive breast cancer," she added ... "The headline result is that 6 months is as good as 12 months. This is a real-world result, but we need to be very ... read more

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects

A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 months ... of treatment can be as good as the standard ... read more

Test of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects

A new study finds that women who have been diagnosed with early-stage HER2-positive breast cancer did just as well with six months of treatment with the drug Herceptin (trastuzumab) as did women who received a 12 ... dose could be reduced to good effect ... read more

Shorter drug treatment OK for many women with breast cancer

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests. It’s good ... read more

Breast Cancer Patients May Shorten Herceptin Regimen: Study

"HER2-positive breast cancer ... of the women took Herceptin for six months, while the other half remained on the standard 12-month regimen. Outcomes were tracked for four years. Earl's group reported that six months of Herceptin was just as effective ... read more

Study Finds More Isn't Better for Widely Used Breast Cancer Drug

For more than a decade, women with a dangerous form of breast cancer have relied on Roche Holding AG’s blockbuster drug Herceptin, taking the $76,700-a-year medicine for 12 months ... patients can receive six months when that duration is effective ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us